Pacifica Partners’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.5K | Sell |
7,329
-290
| -4% | -$1.05K | 0.01% | 248 |
|
|
2025
Q1 | $15.8K | Hold |
7,619
| – | – | 0.01% | 300 |
|
|
2024
Q4 | $23K | Hold |
7,619
| – | – | 0.01% | 267 |
|
|
2024
Q3 | $19.8K | Hold |
7,619
| – | – | 0.01% | 297 |
|
|
2024
Q2 | $20.6K | Sell |
7,619
-1,000
| -12% | -$2.71K | 0.01% | 296 |
|
|
2024
Q1 | $39.4K | Buy |
8,619
+3,799
| +79% | +$17.4K | 0.02% | 231 |
|
|
2023
Q4 | $21.6K | Buy |
4,820
+2,185
| +83% | +$9.81K | 0.01% | 297 |
|
|
2023
Q3 | $11.6K | Hold |
2,635
| – | – | 0.01% | 327 |
|
|
2023
Q2 | $17.2K | Hold |
2,635
| – | – | 0.01% | 251 |
|
|
2023
Q1 | $19K | Hold |
2,635
| – | – | 0.01% | 250 |
|
|
2022
Q4 | $25K | Hold |
2,635
| – | – | 0.02% | 210 |
|
|
2022
Q3 | $28K | Hold |
2,635
| – | – | 0.02% | 202 |
|
|
2022
Q2 | $27K | Buy |
2,635
+230
| +10% | +$2.36K | 0.02% | 215 |
|
|
2022
Q1 | $23K | Hold |
2,405
| – | – | 0.02% | 226 |
|
|
2021
Q4 | $29K | Hold |
2,405
| – | – | 0.02% | 215 |
|
|
2021
Q3 | $51K | Buy |
2,405
+760
| +46% | +$16.1K | 0.04% | 154 |
|
|
2021
Q2 | $33K | Buy |
1,645
+1,600
| +3,556% | +$32.1K | 0.03% | 176 |
|
|
2021
Q1 | $1K | Hold |
45
| – | – | ﹤0.01% | 388 |
|
|
2020
Q4 | $2K | Buy |
+45
| New | +$2K | ﹤0.01% | 339 |
|